Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Innovus Acquires Semprae Labs | Contract Pharma

What are you searching for?

Sign in
Breaking News

Innovus Acquires Semprae Labs

Gains two OTC women’s health products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Innovus Pharmaceuticals, Inc. has acquired Semprae Laboratories, Inc. Based in NJ, Semprae focuses on developing products for women’s sexual health and currently markets two OTC products, Zestra and Zestra Glide, which had sales of approximately $1 million in 2013.
 
Innovus Pharma currently has two products targeting male sexual health including EjectDelay for premature ejaculation and CIRCUMserum to help alleviate reduced sensitivity.
 
“This acquisition of Semprae moves Innovus Pharma into the commercial revenue-generating stage with needed products in the female sexual health space,” said Dr. Bassam Damaj, president and chief executive officer of Innovus Pharma. “In addition, it gives Innovus the needed retail infrastructure for distributing the rest of our OTC products in the U.S. The combination of Semprae’s two products with those of Innovus Pharma creates a company that is clearly an emerging leader in the over the counter male and female sexual health space.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters